Vaccines & Biopharmaceuticals
Cell lines, Processes and Products for Today and Tomorrow
-
microbial cell line and process development
-
VLP based vaccines
-
ready-to-transfer processes
-
technology transfer and implementation support
-
protein analytics
-
manufacturing of preclinical and clinical material
ARTES part of “Worldwide, researchers work on coronavirus vaccine”
ARTES joins global combat against Corona
ARTES receives Renewal of French Research Tax Credit (CIR) Accreditation